These results suggest that CUDC-907-mediated downregulation of MYC expression attenuates the transcriptional regulation of CKIs, leading to an increase in the expression of P21 and P27, thereby inhibiting the corresponding cyclins and CDKs, which eventually leads to G0/G1 phase arrest and exerts anti-tumor effects. The gene discussed is MYC; the disease is neoplasm.